Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen T Chifotides

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2024
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic MastocytosisHelen T Chifotides, Prithviraj Bose
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia VeraLucia Masarova, Helen T Chifotides
Blood|October 2, 2024
How I individualize selection of JAK inhibitors for patients with myelofibrosisLucia Masarova, Helen T Chifotides
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
New Therapies in Development for MyelofibrosisHelen T Chifotides, Srdan Verstovsek
Journal of the American Chemical Society|September 22, 2007
Unprecedented head-to-head right-handed cross-links between the antitumor bis(mu-N,N'-di-p-tolylformamidinate) dirhodium(II,II) core and the dinucleotide d(ApA) with the adenine bases in the rare imino formHelen T Chifotides, Kim R Dunbar
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 11, 2008
Head-to-head right-handed cross-links of the antitumor-active bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) unit with the dinucleotides d(GpA) and d(ApG)Helen T Chifotides, Kim R Dunbar
Chemical Communications (Cambridge, England)|August 19, 2007
Guanine binding to dirhodium tetracarboxylate anticancer complexes: quantum chemical calculations unravel an elusive mechanismDirk V Deubel, Helen T Chifotides
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 11, 2006
Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG)Helen T Chifotides, Kim R Dunbar
Accounts of Chemical Research|February 16, 2005
Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNAHelen T Chifotides, Kim R Dunbar
Accounts of Chemical Research|March 13, 2013
Anion-π interactions in supramolecular architecturesHelen T Chifotides, Kim R Dunbar
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2024
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic MastocytosisHelen T Chifotides, Prithviraj Bose
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia VeraLucia Masarova, Helen T Chifotides
Blood|October 2, 2024
How I individualize selection of JAK inhibitors for patients with myelofibrosisLucia Masarova, Helen T Chifotides
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
New Therapies in Development for MyelofibrosisHelen T Chifotides, Srdan Verstovsek
Journal of the American Chemical Society|September 22, 2007
Unprecedented head-to-head right-handed cross-links between the antitumor bis(mu-N,N'-di-p-tolylformamidinate) dirhodium(II,II) core and the dinucleotide d(ApA) with the adenine bases in the rare imino formHelen T Chifotides, Kim R Dunbar
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 11, 2008
Head-to-head right-handed cross-links of the antitumor-active bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) unit with the dinucleotides d(GpA) and d(ApG)Helen T Chifotides, Kim R Dunbar
Chemical Communications (Cambridge, England)|August 19, 2007
Guanine binding to dirhodium tetracarboxylate anticancer complexes: quantum chemical calculations unravel an elusive mechanismDirk V Deubel, Helen T Chifotides
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 11, 2006
Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG)Helen T Chifotides, Kim R Dunbar
Accounts of Chemical Research|February 16, 2005
Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNAHelen T Chifotides, Kim R Dunbar
Accounts of Chemical Research|March 13, 2013
Anion-π interactions in supramolecular architecturesHelen T Chifotides, Kim R Dunbar
Pageof 5